SCOPUS 정보 검색 플랫폼

European Journal of Pharmaceutical Sciences

Volumn 12, Issue 1, 2000, Pages 41-50

The role of P-glycoprotein in determining the oral absorption and clearance of the NK2 antagonist, UK-224,671

(4) Beaumont, Kevin a Harper, Alison a Smith, Dennis A a Bennett, Joanne a

a PFIZER GLOBAL RESEARCH AND DEVELOPMENT (United Kingdom)

Author keywords

Oral absorption; P glycoprotein; Transgenic mice; UK 224,671

Indexed keywords

CYTOCHROME P450 ISOENZYME; GLYCOPROTEIN P; NEUROKININ 2 RECEPTOR ANTAGONIST; UK 224671; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG EXCRETION; DRUG METABOLISM; EPITHELIUM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE ABSORPTION; MALE; MOUSE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RAT; TRANSGENIC MOUSE;

EID: 0033730609 PISSN: 09280987 EISSN: None Source Type: Journal
DOI: 10.1016/S0928-0987(00)00144-5 Document Type: Article

Times cited : (38)

References (27)

1
- 0025311288
- Epithelial transport of drugs in cell culture. 1. A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells
- (1990) J. Pharm. Sci. , vol.79 , pp. 476-482
- Artursson, P.¹

2
- 0033949514
- Abel, S., 2000. Pharmacokinetics and metabolism of UK-224,671 in rat, dog and man
- (2000) Xenobiotica , vol.30 , pp. 627-642
- Beaumont, K.¹ Harper, A.M.² Smith, D.A.³

3
- 0018967595
- Interspecies variation in liver weight, hepatic blood flow and antipyrine clearance: extrapolation of data to benzodiazepines and phenytoin
- (1980) J. Pharmacokinet. Biopharm. , vol.8 , pp. 165-176
- Boxenbaum, H.¹

4
- 0000312699
- Physicochemical and drug-delivery considerations for oral drug bioavailability
- (1996) Drug Disc. Today , vol.1 , pp. 461-473
- Chan, O.H.¹ Stewart, B.H.²

5
- 0029999340
- Direct demonstration of small intestinal secretion and site dependent absorption of the β-blocker talinolol in humans
- (1996) Clin. Pharm. Ther. , vol.59 , pp. 541-549
- Gramatte, T.¹ Oertel, R.² Terhaag, B.³ Kirch, W.⁴

6
- 0032949332
- Molecular and physical mechanisms of first pass extraction
- (1999) Drug Metab. Dispos. , vol.27 , pp. 161-166
- Hall, S.D.¹ Thummel, K.E.² Watkins, P.B.³ Lown, K.S.⁴ Benet, L.Z.⁵ Paine, M.F.⁶ Mayo, R.R.⁷ Turgeon, D.K.⁸ Bailey, D.G.⁹ Fontana, R.J.¹⁰ Wrighton, S.A.¹¹

7
- 0343416856
- Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery
- (1997) Adv. Drug Deliv. Rev. , vol.27 , pp. 201-214
- Hebert, M.F.¹

8
- 0343488673
- Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption
- (1997) Adv. Drug Deliv. Rev. , vol.25 , pp. 129-157
- Hunter, J.¹ Hirst, B.H.²

9
- 0028303363
- The contribution of intestinal secretion to the dose dependent absorption of celiprolol
- (1994) Pharm. Res. , vol.11 , pp. 648-653
- Kuo, S.M.¹ Whitby, B.R.² Artursson, P.³ Ziemniak, J.A.⁴

10
- 0031863355
- Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine
- (1998) J. Pharm. Exp. Ther. , vol.285 , pp. 1104-1112
- Lampen, A.¹ Zhang, Y.² Hackbarth, I.³ Benet, L.Z.⁴ Sewing, K.F.⁵ Christians, U.⁶

11
- 0027315394
- Presystemic elimination of the β-blocker pafenolol in the rat after oral and intraperitoneal administration and identification of a main metabolite in both rats and humans
- (1993) Drug Metab. Dispos. , vol.21 , pp. 435-440
- Lennernas, H.¹ Renberg, L.² Hoffman, K.J.³ Regardh, C.G.⁴

12
- 0027178256
- Dose dependent intestinal absorption and significant intestinal excretion of pafenolol in the rat
- (1993) Pharm. Res. , vol.10 , pp. 727-731
- Lennernas, H.¹ Regardh, C.G.²

13
- 0031024171
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
- (1997) Adv. Drug Deliv. Rev. , vol.23 , pp. 3-25
- Lipinski, C.A.¹ Lombardo, F.² Dominy, B.W.³ Feeney, P.J.⁴

14
- 0030982634
- Grapefruit juice increase felodipine oral availability in humans by decreasing intestinal CYP3A protein expression
- (1997) J. Clin. Invest. , vol.99 , pp. 2545-2553
- Lown, K.S.¹ Bailey, D.G.² Fontana, R.J.³ Janarden, S.K.⁴ Adair, C.H.⁵ Fortlage, M.B.⁶ Brown, M.B.⁷ Guo, W.⁸ Watkins, P.B.⁹

15
- 0029860174
- Substantial excretion of digoxin via the intestinal mucosa and prevention of long term digoxin accumulation in the brain by the mdr1a P-glycoprotein
- (1996) Br. J. Pharm. , vol.119 , pp. 1038-1044
- Mayer, U.¹ Wagenaar, E.² Beijnen, J.H.³ Smit, J.W.⁴ Meijer, D.K.F.⁵ Van Asperen, J.⁶ Borst, P.⁷ Schinkel, A.H.⁸

16
- 0030222256
- Structural requirements for intestinal absorption of peptide drugs
- (1996) J. Contol. Release , vol.41 , pp. 3-17
- Pauletti, G.M.¹ Gangwar, S.² Knipp, G.T.³ Nerurkar, M.N.⁴ Okumu, F.W.⁵ Tamura, K.⁶ Siahaan, T.J.⁷ Borchardt, R.T.⁸

17
- 0028229150
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
- (1994) Cell , vol.77 , pp. 491-502
- Schinkel, A.H.¹ Smit, J.J.M.² van Tellingen, O.³ Beijnen, J.H.⁴ Wagenaar, E.⁵ van Deemter, L.⁶ Mol, C.A.A.M.⁷ van der Valk, M.A.⁸ Robanus-Maandag, E.C.⁹ Te Riele, H.P.J.¹⁰ Berns, A.J.M.¹¹ Borst, P.¹²

18
- 0028825399
- Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporine A
- (1995) J. Clin. Invest. , vol.96 , pp. 1698-1705
- Schinkel, A.H.¹ Wagener, E.² van Deemter, L.³ Mol, C.A.A.M.⁴ Borst, P.⁵

19
- 4243801613
- Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug transporting) P-glycoproteins
- (1997) Proc. Natl. Acad. Sci. USA , vol.94 , pp. 4028-4033
- Schinkel, A.H.¹ Mayer, U.² Wagenaar, E.³ Mol, C.A.A.M.⁴ van Deemter, L.⁵ Smit, J.J.M.⁶ Van der Valk, M.A.⁷ Voordouw, A.C.⁸ Spits, H.⁹ van Tellingen, O.¹⁰ Ziljman, J.M.¹¹ Fibbe, W.E.¹² Borst, P.¹³

20
- 0031982725
- Pharmacological insights from P-glycoprotein knockout mice
- (1998) Int. J. Clin. Pharm. Ther. , vol.36 , pp. 9-13
- Schinkel, A.H.¹

21
- 0031837161
- Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdr1a and mdr1b genes have been disrupted
- (1998) Br. J. Pharm. , vol.124 , pp. 416-424
- Smit, J.W.¹ Schinkel, A.H.² Weert, B.³ Meijer, D.K.F.⁴

22
- 0031962002
- P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound
- (1998) Int. J. Clin. Pharm. Ther. , vol.36 , pp. 16-24
- Spahn-Langguth, H.¹ Baktir, G.² Radschuweit, A.³ Okyar, A.⁴ Terhaag, B.⁵ Ader, P.⁶ Hanafy, A.⁷ Langguth, P.⁸

23
- 0023447098
- Cellular localisation of the multidrug resistance gene product P-glycoprotein in normal human tissues
- (1987) Proc. Natl. Acad. Sci. , vol.84 , pp. 7734-7738
- Thiebaut, F.¹ Tsuro, T.² Hamada, H.³ Gottesman, M.M.⁴ Pastan, I.⁵ Willingham, M.C.⁶

24
- 0030581087
- Active secretion and enterocytic drug metabolism barriers to drug absorption
- (1996) Adv. Drug Deliv. Rev. , vol.20 , pp. 99-112
- Wacher, V.J.¹ Salphati, L.² Benet, L.Z.³

25
- 0029986922
- Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration and dose dependent absorption in vitro and in vivo
- (1996) Pharm. Res. , vol.13 , pp. 514-522
- Wetterich, U.¹ Spahn-Langguth, H.² Mutschler, E.³ Terhaag, B.⁴ Rosch, W.⁵ Langguth, P.⁶

26
- 0032101275
- The pharmacological role of P-glycoprotein in the intestinal epithelium
- (1998) Pharmacol. Res. , vol.37 , pp. 429-435
- Van Asperen, J.¹ Van Tellingen, O.² Beijnen, J.H.³

27
- 0030990079
- In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man - Fact or myth?
- (1997) Pharm. Res. , vol.14 , pp. 763-766
- Yee, S.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.